Menu Menu

CYTO    Altamira Therapeutics Ltd    1601936    
Income Statement
Net Income 4,339,832

Balance Sheet
Current Assets 524,013
Assets 8,069,173
Current Liabilities 1,227,865
Liabilities 1,750,858
Equity 6,318,315
Shares Out 2,240,000

Cash Flow Statement
Investing Cash Flow 621

Market Analysis
Market Cap 1,702,589
Price 0.26
BVPS 2.82
PB 0.09
EPS -1.42
PS 0.08
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
4/10
Jul Aug Sep
9/24
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view CYTO documents filed with the SEC.


CYTO Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: